JPH04504842A - Ａｉｄｓ、ａｒｃおよびｈｉｖ感染の治療または予防のための組成物および方法 - Google Patents

Ａｉｄｓ、ａｒｃおよびｈｉｖ感染の治療または予防のための組成物および方法

Info

Publication number
JPH04504842A
JPH04504842A JP2502884A JP50288490A JPH04504842A JP H04504842 A JPH04504842 A JP H04504842A JP 2502884 A JP2502884 A JP 2502884A JP 50288490 A JP50288490 A JP 50288490A JP H04504842 A JPH04504842 A JP H04504842A
Authority
JP
Japan
Prior art keywords
protein
soluble
patient
administered
rst4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2502884A
Other languages
English (en)
Japanese (ja)
Inventor
レットビン，ノーマン　エー．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Publication of JPH04504842A publication Critical patent/JPH04504842A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2502884A 1989-01-18 1990-01-18 Ａｉｄｓ、ａｒｃおよびｈｉｖ感染の治療または予防のための組成物および方法 Pending JPH04504842A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30009689A 1989-01-18 1989-01-18
US300,096 1989-01-18

Publications (1)

Publication Number Publication Date
JPH04504842A true JPH04504842A (ja) 1992-08-27

Family

ID=23157685

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2502884A Pending JPH04504842A (ja) 1989-01-18 1990-01-18 Ａｉｄｓ、ａｒｃおよびｈｉｖ感染の治療または予防のための組成物および方法

Country Status (6)

Country Link
EP (1) EP0454767A1 (de)
JP (1) JPH04504842A (de)
AU (1) AU4964290A (de)
CA (1) CA2045583A1 (de)
OA (1) OA09507A (de)
WO (1) WO1990008198A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756096A (en) * 1991-07-25 1998-05-26 Idec Pharmaceuticals Corporation Recombinant antibodies for human therapy
MX9204374A (es) * 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
US6136310A (en) 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
JP4646157B2 (ja) * 2007-12-25 2011-03-09 財団法人山形県産業技術振興機構 有機エレクトロルミネッセンス材料およびそれを用いた素子

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3134874B2 (ja) * 1986-08-21 2001-02-13 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク Ｔ細胞表面タンパク質ｔ４をコードするｄｎａ並びにｔ４フラグメントのａｉｄｓ治療への使用

Also Published As

Publication number Publication date
AU4964290A (en) 1990-08-13
EP0454767A1 (de) 1991-11-06
CA2045583A1 (en) 1990-07-19
OA09507A (en) 1992-11-15
WO1990008198A1 (en) 1990-07-26

Similar Documents

Publication Publication Date Title
US5756666A (en) Peptides capable of inducing immune response to HIV
DE69733352T2 (de) Hla-a2.1 bindende peptide und deren verwendung
JPWO1995011255A1 (ja) Ｈｉｖに対する免疫応答を誘導できるペプチド及びペプチドを含む抗ａｉｄｓ予防・治療剤
NL8602422A (nl) Recombinant-virus, antigeen peptide of eiwit, vaccin tegen verworven immuundeficientiesyndroom, vector voor recombinant-dna en eencelligen die deze vector bevatten.
MXPA02010374A (es) Composiciones y metodos para tratar infecciones virales.
JP2018502095A (ja) 眼疾患治療のペプチド及びこれを含む眼疾患治療用組成物
CN102883736A (zh) 用于促进血管生成的肽及其用途
CA2332642C (en) Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
DE69517521T2 (de) Peptid aus dem inneren des hepatitis-c-virus brauchbar für die stimulation cytotoxischer t-lymphocyten und die diagnose des hcv-kontaktes
JP2001515048A (ja) 百日咳毒素ｂオリゴマーによる抗ウイルス療法
CA2374681C (en) Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
RU2555345C2 (ru) Лечение хориоидальной неоваскуляризации с помощью вакцин
CN101735314A (zh) 骨桥蛋白及其护肝用途
US20040197330A1 (en) Compositions comprising DC-SIGN blockers and methods of using DC-SIGN blockers for preventing or treating diseases of a mammal, including viral infections
CN100408595C (zh) Sars病毒hla-a2限制性表位多肽及其应用
AU723905B2 (en) Treatment of HIV-infection by interfering with host cell cyclophilin receptor activity
AU4964290A (en) Compositions and methods for treating or preventing aids, arc and hiv infection
AU719203B2 (en) Use of proteins as anti-retroviral agents
DK173667B1 (da) Små peptider, der hæmmer binding til T-4 receptorer og virker som immunogener, farmaceutisk produkt som omfatter mindst 1 af peptiderne samt prøveudstyr til påvisning af antistoffer
JPH06199894A (ja) Ｃ型肝炎ウイルスのコア蛋白質領域に存在するｔ細胞エピトープ
US20090054330A1 (en) Novel Therapeutic Use of Viral Inflammation Modulatory Protein in Blocking Xenograft Rejection
AU763900B2 (en) Treatment of HIV-infection by interfering with host cell cyclophilin receptor activity
JP2002125678A (ja) Ｃ型肝炎ウイルスの新規なｃｔｌエピトープ
JPH02504641A (ja) 可溶性ｔ４蛋白質と抗レトロウィルス剤との組合せ並びにａｉｄｓ、ａｒｃおよびｈｉｖ感染の処置または防止方法
Jardim Immunological and biochemical characterization of the major surface membrane proteins: gp63 and the lipophosphoglycan associated protein of Leishmania